XML 43 R31.htm IDEA: XBRL DOCUMENT
v3.25.1

Liability Related to Sale of Future Royalties (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Liability Related to Sale of Future Royalties [Abstract] |
Liability Related to Sale of Future Royalties | The following table sets forth information on our liability related to sale of future royalties (in thousands):
Liability related to sale of future royalties, net as of December 31, 2024 |  | $ | 542,212 |
Royalty payments to Royalty Pharma |  |  | (12,891 | )
Interest expense related to sale of future royalties |  |  | 18,670 |
Amortization of issuance costs related to sale of future royalties |  |  | 152 |
Liability related to sale of future royalties, net as of March 31, 2025 |  | $ | 548,143 |
Less: Current portion (1) |  |  | (12,002 | )
Liability related to sale of future royalties, net as of March 31, 2025 – Non-current |  | $ | 536,141 |
(1) | Included in other current liabilities in our condensed consolidated balance sheet.

X
- References No definition available. + Details
Name: | us-gaap_OtherLiabilitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of other noncurrent liabilities. + References No definition available. + Details
Name: | us-gaap_OtherNoncurrentLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration